HIGHLIGHTS
- who: Aseel Alsuwayegh and colleagues from the Corporate Department of Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia have published the Article: Cost Consequence Analysis of Belimumab versus Standard of Care for the Management of Systemic Lupus Erythematosus in Saudi Arabia: A Retrospective Cohort Study, in the Journal: (JOURNAL) of 21/03/2020
- what: The aim of this study was to compare the and effectiveness of belimumab versus the SoC alone for the management of SLE using real-world data from the perspective of public healthcare payers in Saudi Arabia. The authors demonstrated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.